BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2000

View Archived Issues

Watson to acquire Schein

Read More

Ivax to develop treatment for cystic fibrosis with CBR

Read More

Way to increase cord blood stem cell production discovered by Aastrom

Read More

deCODE Genetics establishes research agreement with Partners

Read More

Daiichi licenses Captisol technology from CyDex

Read More

CD40 agonist MAbs reduce disease severity in a mouse model of rheumatoid arthritis

Read More

ImClone Systems commences phase I trial of antiangiogenesis agent IMC-1C11

Read More

Intellivax and Active Biotech form partnership to develop streptococcal vaccine

Read More

Genentech's single-injection clot buster for heart attack approved by FDA

Read More

Immunomedics reports phase II results of CEA-Cide as colorectal cancer therapy

Read More

Vical's cationic lipid formulation selectively enhances antibody immune response to antigen pDNA

Read More

ASGT presentation documents enhanced antitumor activity for p53 attached to VP22

Read More

NDA submitted for fast-dissolving Zomig

Read More

Abarelix depot versus currently used therapies for prostate cancer: results of pivotal trials

Read More

Arimidex receives Canadian approval for treatment of advanced breast cancer

Read More

Anticholinergics in the pipeline at Sumitomo for urinary incontinence

Read More

New compounds from Sanofi-Synthelabo preferably contract urethral smooth muscle and veins

Read More

Novel 5-HT1A receptor ligands from SCRAS particularly useful in hypertension Rx

Read More

Benzimidazoles synthesized at Takeda act as GnRH antagonists

Read More

Calcium channel blockers in development at Questcor as neuroprotective agents

Read More

Series of heparin antagonist peptides described by Commonwealth Biotechnologies

Read More

Furopyridine antibacterials discovered by Pfizer

Read More

New GH secretagogues specifically claimed for use in type II diabetes

Read More

New expanded indication of Enbrel approved by FDA

Read More

Myriad Genetics identifies novel prostate cancer gene as part of Schering-Plough collaboration

Read More

Sangamo and R.W. Johnson establish collaborative research program

Read More

ISIS-3521 to be advanced to phase III trials for NSCLC based on recent results

Read More

Eos Biotechnology and Aventis Pasteur enter cancer vaccine agreement

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • Pancreas

    Sonire starts US study of cancer HIFU after $18M series A

    BioWorld
    Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
  • Coreterra Therapeutics patents agents for schizophrenia

    BioWorld Science
    Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing